house · trading 2020-02-12 → 2020-03-07
*Notional-weighted price return on disclosed buys from the last ~3 years, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2020-03-07 | GSK | BUY | $1K–$15K | $42.38 | $50.45 2026-08-13 | +19.0% |
| 2020-03-04 | AMD | BUY | $1K–$15K | $50.11 | $483.01 2026-08-13 | +863.9% |
| 2020-02-26 | GSK | BUY | $1K–$15K | $41.90 | $50.45 2026-08-13 | +20.4% |
| 2020-02-12 | GSK | BUY | $1K–$15K | $44.23 | $50.45 2026-08-13 | +14.1% |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Thomas H Tuberville | 2 · AMD, GSK |
| John Boozman | 2 · AMD, GSK |
| Rohit Khanna | 2 · AMD, GSK |
| Mike Kelly | 2 · AMD, GSK |
| Marjorie Taylor Mrs Greene | 2 · AMD, GSK |
| Roger W. Marshall | 2 · AMD, GSK |
| David Kustoff | 2 · AMD, GSK |
| James B. Renacci | 1 · GSK |
| Josh Gottheimer | 1 · AMD |
| Thomas R Carper | 1 · GSK |
| Virginia Foxx | 1 · GSK |
| K. Michael Conaway | 1 · GSK |